Tumor markers in hemodialysis patients

Author： Arican A.   Ozdemir N.   Sezer S.   Erten Y.   Guz G.   Turan M.   Inanoglu I.   Haberal M.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.31, Iss.8, 1999-12, pp. : 3367-3368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of Serological Markers of Autoimmunity in Hemodialysis Patients with Hepatitis C Virus

By Ozdemir F.N.   Turan M.   Sezer S.   Kayatas M.   Haberal A.   Guz G.   Erten Y.   Hizel N.   Boyacioglu S.   Gulmus S.   Bilgin N.  

Transplantation Proceedings, Vol. 30, Iss. 3, 1998-05 ,pp. : 848-849

Elsevier

Access to resources Recommend Favorite

The gene expression of TNF-α and ICAM-1 as novel markers for atherosclerosis in Egyptian hemodialysis patients

By El-Sayed Laila H.  

International Journal of Immunological Studies, Vol. 1, Iss. 1, 2009-02 ,pp. : 94-105

Inderscience Publishers

Access to resources Recommend Favorite

Sleep disorders in hemodialysis patients

By Abella Rodriguez M.   Merino D.   Grizzo M.   Schiavelli R.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3082-3082

Elsevier

Access to resources Recommend Favorite

Anticardiolipin antibodies in hemodialysis patients

By Ozdemir N.   Guz G.   Sezer S.   Haberal A.   Ayaz H.   Haberal M.  

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3388-3389

Elsevier

Access to resources Recommend Favorite

Tumor markers for hepatocellular carcinoma (Review)

By      

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 593-598

Spandidos Publications

Access to resources Recommend Favorite